Tisagenlecleucel
HY-P99338
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameTisagenlecleucel
- Delivery Days Customer10
- CertificationResearch Use Only
- Scientific DescriptionTisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma[1][2].
- UNSPSC12352203